GIORGINO, FRANCESCO LIBERO
 Distribuzione geografica
Continente #
NA - Nord America 1.009
EU - Europa 80
AS - Asia 68
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.161
Nazione #
US - Stati Uniti d'America 1.008
CN - Cina 59
IT - Italia 47
FI - Finlandia 7
GB - Regno Unito 7
IN - India 6
DE - Germania 3
FR - Francia 3
IE - Irlanda 3
SE - Svezia 3
UA - Ucraina 3
NL - Olanda 2
AR - Argentina 1
BO - Bolivia 1
ES - Italia 1
EU - Europa 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SG - Singapore 1
VN - Vietnam 1
Totale 1.161
Città #
Fairfield 199
Chandler 96
Ashburn 91
Woodbridge 88
Seattle 86
Houston 80
Cambridge 78
Wilmington 61
Ann Arbor 59
San Diego 22
Beijing 16
Medford 13
Princeton 13
Padova 12
Des Moines 11
Nanjing 9
Roxbury 6
Helsinki 5
Ardea 4
Arnesano 4
Dearborn 4
Glassboro 4
Guangzhou 4
Kunming 4
Boardman 3
Dublin 3
Hebei 3
Jiaxing 3
Kharkiv 3
Milan 3
Shenyang 3
Guidizzolo 2
Haikou 2
Pune 2
Rome 2
Rouen 2
Tianjin 2
Altamura 1
Bandra 1
Borgosesia 1
Brendola 1
Campana 1
Changsha 1
Chengdu 1
Chiswick 1
Cochabamba 1
Frankfurt am Main 1
Fuzhou 1
Groningen 1
Hangzhou 1
Hounslow 1
Islington 1
Jinan 1
Kilburn 1
Lanzhou 1
Lima 1
Madrid 1
Manila 1
Martina Franca 1
Nanchang 1
Naples 1
Ningbo 1
Panama City 1
Piombino 1
Redwood City 1
Reggello 1
San Severo 1
Shanghai 1
Singapore 1
Taiyuan 1
Verona 1
Vicenza 1
Wuhan 1
Ziano di Fiemme 1
Totale 1.039
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 160
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 131
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 105
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly 94
Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists 92
Patient-reported outcomes in elderly patients with type 2 diabetes mellitus treated with dual oral therapy: a multicenter, observational study from Italy 91
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 88
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 81
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly 79
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 77
Thyroid function in Klinefelter syndrome: a multicentre study from KING group 66
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 65
Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome 49
Totale 1.178
Categoria #
all - tutte 4.160
article - articoli 4.160
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.320


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201980 0 0 0 0 0 0 0 0 0 0 40 40
2019/2020311 26 13 2 23 31 18 42 44 37 33 16 26
2020/2021205 4 42 11 7 8 8 5 18 27 41 27 7
2021/2022245 9 25 49 27 19 3 10 28 4 2 22 47
2022/2023194 36 25 8 17 23 21 5 25 25 0 9 0
2023/202458 2 14 15 7 5 7 3 1 0 4 0 0
Totale 1.178